Celltrion | 068270 - 债务

金融业

KRW

KRW 768.81B

现金及等价物

KRW 56.79B

KRW 92.83B

KRW 481.57B

KRW 292.71B

KRW 160.58B

股息收益率

0.38

KRW 13.41B

KRW 19.64B

1.07K

EPS每股收益

KRW 1.35K

股本和储备

KRW 434.82B

KRW 39.29B

债务利息支出

KRW 19B

KRW 779.01M

KRW 411.27B

KRW 43487.05B

KRW 8.82B

KRW 119.22B

KRW 12.9B

普通股股本

KRW 229.65M

58.97

KRW 11.84B

KRW 1240B

销售和管理费用

KRW 9.32B

KRW 126B

贸易债权人

KRW 88.58B

应收帐款人

KRW 2009.82B

	债务	更改		日
Akebia Therapeutics	USD 46.51M		7.82M	2025-03
Alaunos Therapeutics	USD 10.99M		5.78M	2023-03
Avita Medical	AUD 46.05M		1.46M	2025-12
Celltrion	KRW 160.58B		733.3M	2026-03
Dianthus Therapeutics	USD 1.36M		79K	2026-03
Ionis Pharmaceuticals	USD 1.91B		425.5M	2026-06
IQVIA Holdings	USD 16.24B		408M	2026-06
Moderna	USD 1.3B		7M	2026-03
Organon & Co	USD 8.55B		16M	2026-06
Revvity	USD 3.35B		48.03M	2026-03
Tectonic Therapeutic	USD 876K		115K	2024-12
Viatris	USD 13.35B		993.3M	2026-06
Xeris Pharmaceuticals	USD 258.55M		899K	2026-03